EUVIMEDScopri EUVIMED
MetaanalyseSystematische ÜbersichtÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis

Inês Rego de Figueiredo iD, Filipa Sofia Simas, Angela Ghiletchi, João Oliveira Torres, José Silva-Nunes

Obesity · 2026-09 · 34 (S2) · 25-35

DOI: 10.1002/oby.70098 ↗

At a glance

Metaanalyse in Obesity, published online on 2026-02-04. Written by Inês Rego de Figueiredo and 4 co-authors. Institution: Multidisciplinary Unit of Bariatric and Metabolic Surgery, Curry Cabral Hospital, Unidade Local de Saúde São José, Centro Clínico Académico de Lisboa…. Major MEDLINE topics: Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Hypoglycemic Agents. Cited 13 times so far (Crossref); 16 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

This meta‐analysis evaluates the safety and efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) for the treatment of older adults with obesity compared to younger individuals.

Methods

A systematic review was conducted following PRISMA guidelines (PROSPERO CRD420251074381). PubMed, Embase, and Scopus were searched until May 17, 2025, for randomized controlled trials and observational studies assessing GLP‐1 RA in adults ≥ 65 years with obesity with or without type 2 diabetes. Random effects meta‐analyses calculated the log odds ratios (LOR) for dichotomous outcomes and the mean differences (MD) for continuous outcomes, with equivalence testing via two one‐sided tests (TOST) and meta‐regression for baseline adjustments.

Results

Five studies involving 1229 participants were included. No significant difference in serious adverse events was found between older and younger adults (pooled LOR: 0.06, p = 0.9). Older adults had a trend toward lower frequency of nausea (LOR: −0.44, p = 0.06) but higher incidence of constipation (LOR: 0.72, p = 0.02) and hypoglycemia (LOR: 0.97, p < 0.001). Efficacy in metabolic and weight control was comparable. Additionally, one study suggested that liraglutide could reduce fat mass without worsening sarcopenia.

Conclusions

GLP‐1 RA therapy seems to be safe and effective in older adults with obesity, achieving similar effects on weight loss and glycemic control as in younger individuals.

Subjects

MeSH terms (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsObesityHypoglycemic AgentsHumansAgedDiabetes Mellitus, Type 2LiraglutideRandomized Controlled Trials as TopicTreatment OutcomeFemaleGlucagon-Like Peptide-1 ReceptorWeight LossConstipationNausea

Author keywords

efficacyelderly with obesityglucagon‐like peptide‐1 receptor agonistssafety

Substances

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsLiraglutideGlucagon-Like Peptide-1 Receptor

Authors and institutions

  • Multidisciplinary Unit of Bariatric and Metabolic Surgery, Curry Cabral Hospital, Unidade Local de Saúde São José, Centro Clínico Académico de Lisboa, Lisbon, Portugal.
  • Egas Moniz School of Health and Science, Almada, Portugal.
  • NOVA Medical School/Faculdade de Ciencias Medicas, New University of Lisbon, Lisbon, Portugal.
  • Department of Nutrition, Curry Cabral Hospital, Unidade Local de Saúde São José, Centro Clínico Académico de Lisboa, Lisbon, Portugal.
  • Department of Internal Medicine, Hospital Garcia de Orta, Unidade Local de Saúde Almada-Seixal, Almada, Portugal.
  • Department of Endocrinology, Diabetes, and Metabolism, Curry Cabral Hospital, Unidade Local de Saúde São José, Centro Clínico Académico de Lisboa, Lisbon, Portugal.

ORCID profiles: Inês Rego de Figueiredo

Cite

APA

Rego de Figueiredo, I., Simas, F. S., Ghiletchi, A., Oliveira Torres, J., & Silva-Nunes, J. (2026). Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis. Obesity, 34(S2), 25-35. https://doi.org/10.1002/oby.70098

Vancouver

Rego de Figueiredo I, Simas FS, Ghiletchi A, Oliveira Torres J, Silva-Nunes J. Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis. Obesity. 2026;34(S2):25-35. doi:10.1002/oby.70098

BibTeX
@article{RegodeFigueiredo2026,
  author = {Rego de Figueiredo, Inês and Simas, Filipa Sofia and Ghiletchi, Angela and Oliveira Torres, João and Silva-Nunes, José},
  title = {Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis},
  journal = {Obesity},
  year = {2026},
  volume = {34},
  number = {S2},
  pages = {25--35},
  doi = {10.1002/oby.70098}
}
Start for free →